- Home
- GTE vs LFCR Comparison
GTE vs LFCR Comparison
Compare GTE & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- LFCR
- Stock Information
- Founded
- GTE 2003
- LFCR 1986
- Country
- GTE Canada
- LFCR United States
- Employees
- GTE N/A
- LFCR N/A
- Industry
- GTE Oil & Gas Production
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- GTE Energy
- LFCR Health Care
- Exchange
- GTE Nasdaq
- LFCR Nasdaq
- Market Cap
- GTE 232.6M
- LFCR 214.7M
- IPO Year
- GTE N/A
- LFCR N/A
- Fundamental
- Price
- GTE $7.40
- LFCR $6.48
- Analyst Decision
- GTE Hold
- LFCR Buy
- Analyst Count
- GTE 1
- LFCR 3
- Target Price
- GTE $10.00
- LFCR $8.00
- AVG Volume (30 Days)
- GTE 372.2K
- LFCR 379.4K
- Earning Date
- GTE 02-18-2025
- LFCR 01-02-2025
- Dividend Yield
- GTE N/A
- LFCR N/A
- EPS Growth
- GTE 157.68
- LFCR N/A
- EPS
- GTE 1.43
- LFCR N/A
- Revenue
- GTE $629,503,000.00
- LFCR $130,858,000.00
- Revenue This Year
- GTE $3.86
- LFCR $2.24
- Revenue Next Year
- GTE $16.79
- LFCR $7.88
- P/E Ratio
- GTE $5.19
- LFCR N/A
- Revenue Growth
- GTE N/A
- LFCR 16.47
- 52 Week Low
- GTE $4.72
- LFCR $3.68
- 52 Week High
- GTE $10.40
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- GTE 52.97
- LFCR 45.69
- Support Level
- GTE $7.51
- LFCR $6.13
- Resistance Level
- GTE $8.04
- LFCR $6.58
- Average True Range (ATR)
- GTE 0.38
- LFCR 0.57
- MACD
- GTE -0.00
- LFCR -0.06
- Stochastic Oscillator
- GTE 45.89
- LFCR 40.69
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. It is engaged in the acquisition, exploration, development, and production of oil and gas properties. The firm produces light crude oil, supplemented with medium crude and natural gas. Gran Tierra holds interests in producing and prospective properties in Colombia and prospective properties in Ecuador. The company derives its revenue from Colombia.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.